Delivery Order SPE2DB22D2206-SPE2DB25FKD30
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $48K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $22,092.55 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit dose packaging (10-count units). This firm fixed price contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packaging (10-count). The contract carries a ceiling value of $181,808 under a firm fixed-price arrangement with a completion date of July 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packaging on September 9, 2025. This competitively awarded, non-set-aside contract is valued at $15,578.98 and requires completion by September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, under a firm fixed-price arrangement typical of delivery orders against existing...
- The Defense Logistics Agency awarded a delivery order valued at $6,690.07 to AmerisourceBergen Drug Corp for Tolvaptan 15 mg tablets in unit dose packaging. This non-competitive delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price transaction for pharmaceutical supply. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,444.55 firm fixed price contract is for the delivery of 10-count units of the 30 mg Tolvaptan tablet medication. The delivery order has a completion date of May 22, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tolvaptan 15 mg tablets. The contract has a ceiling value of $7,674.04 and a period of performance running through March 4, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tolvaptan 15 mg tablets. The contract has a ceiling value of $5,077.88 and a completion date of May 28, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOLVAPTAN 15 MG TABLET UD 10S, a medication, with a ceiling value of $13,468.19 and a performance period ending on May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,857.26 to AmerisourceBergen Drug Corp for ITOVEBI 3 MG tablets (28-count package). This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $42,494.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on May 30, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...